Mounjaro Kwikpen 15 mg Solution For Injection (1 Pen 4 Doses)

Key features:
Mounjaro KwikPen is a once-weekly injectable containing Tirzepatide, a dual GIP and GLP-1 receptor agonist. It is used for type 2 diabetes management and weight management in adults, alongside diet and exercise. Tirzepatide improves blood sugar control, reduces appetite, and supports fat loss. It is administered subcutaneously, with doses starting at 2.5 mg weekly and titrated up to 15 mg based on tolerance and response.